Article
Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.
Leukemia - 1 Dec 2018
Bagratuni Tina, Ntanasis-Stathopoulos Ioannis, Gavriatopoulou Maria, Mavrianou-Koutsoukou Nefeli, Liacos Christine, Patseas Dimitrios, Kanellias Nikolaos, Migkou Magdalini, Ziogas Dimitrios C, Eleutherakis-Papaiakovou Evangelos, Roussou Maria, Fotiou Despina, Terpos Evangelos, Kastritis Efstathios, Dimopoulos Meletios A
Abstract excerpt
Liquid biopsyis being integrated into cancer diagnostics with profound therapeutic implications. However, its role in Waldenström's Macroglobulinemia (WM) and IgM monoclonal gammopathies is still unclear. In this study, we evaluated the role of peripheral blood (PB) cell-free DNA (cfDNA) in characterizing the mutational status of MYD88 and CXCR4 of patients with IgM monoclonal gammopathies. Paired bone marrow...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
